gaboxadol has been researched along with Glioblastoma in 1 studies
gaboxadol: GABA agonist; inhibitor of GABA uptake systems; structure
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babateen, O | 1 |
| Jin, Z | 1 |
| Bhandage, A | 1 |
| Korol, SV | 1 |
| Westermark, B | 1 |
| Forsberg Nilsson, K | 1 |
| Uhrbom, L | 1 |
| Smits, A | 1 |
| Birnir, B | 1 |
1 other study available for gaboxadol and Glioblastoma
| Article | Year |
|---|---|
Etomidate, propofol and diazepam potentiate GABA-evoked GABAA currents in a cell line derived from human glioblastoma.
Topics: Anesthetics, General; Cell Line, Tumor; Diazepam; Drug Synergism; Electrophysiological Phenomena; Et | 2015 |